Article Details
Retrieved on: 2021-04-05 20:08:42
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The study is called 'ACTIV-2' and is made up of four new therapies which include monoclonal antibodies, beta interferon and a protease inhibitor.
Article found on: www.kxly.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here